HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin J van den Bent Selected Research

Vincristine (Oncovin)

10/2022Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
11/2021Treatment of anaplastic gliomas: evidences and controversies.
3/2016Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
12/2015Chemotherapy for low-grade glioma: when, for whom, which regimen?
4/2015Joint modeling of longitudinal health-related quality of life data and survival.
1/2015Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.
1/2015Chemotherapy in glioma.
12/2014Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.
1/2014Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
11/2013New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin J van den Bent Research Topics

Disease

64Neoplasms (Cancer)
10/2022 - 08/2003
61Glioma (Gliomas)
12/2022 - 12/2003
58Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2005
19Brain Neoplasms (Brain Tumor)
10/2022 - 08/2003
19Oligodendroglioma
01/2020 - 03/2003
12Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 02/2005
6Lymphoma (Lymphomas)
08/2021 - 10/2010
5Epilepsy (Aura)
04/2022 - 08/2014
4Neoplasm Metastasis (Metastasis)
08/2021 - 01/2018
4Necrosis
11/2019 - 05/2008
4Disease Progression
09/2014 - 03/2003
3Seizures (Absence Seizure)
06/2022 - 01/2021
3Fatigue
06/2017 - 08/2014
2Central Nervous System Neoplasms
01/2022 - 05/2018
2Meningioma (Meningiomas)
08/2021 - 12/2020
2Infections
11/2016 - 08/2014
2Thrombocytopenia (Thrombopenia)
09/2014 - 08/2014
1Mental Fatigue
12/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Circulating Neoplastic Cells
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021
1Respiratory Insufficiency (Respiratory Failure)
12/2021
1Inflammation (Inflammations)
05/2021
1Cognitive Dysfunction
05/2021
1Vision Disorders (Hemeralopia)
01/2021
1Aneuploidy (Aneuploid)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2020
1Cholangiocarcinoma
03/2020
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019
1Central Nervous System Diseases (CNS Diseases)
01/2018
1HIV Infections (HIV Infection)
11/2016

Drug/Important Bio-Agent (IBA)

45Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 12/2003
27Lomustine (CCNU)FDA Link
10/2022 - 02/2005
20Vincristine (Oncovin)FDA LinkGeneric
10/2022 - 02/2005
19Procarbazine (Matulane)FDA Link
10/2022 - 02/2005
12Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 11/2013
12Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2005
11Bevacizumab (Avastin)FDA Link
01/2022 - 11/2007
7Anticonvulsants (Antiepileptic Drugs)IBA
06/2022 - 09/2007
7Pharmaceutical PreparationsIBA
01/2021 - 10/2009
6ErbB Receptors (EGF Receptor)IBA
01/2020 - 02/2006
5Formaldehyde (Formol)FDA Link
01/2019 - 12/2009
5ParaffinIBA
01/2019 - 12/2009
5Alkylating AgentsIBA
10/2012 - 05/2005
4DNA (Deoxyribonucleic Acid)IBA
05/2021 - 01/2015
4Carmustine (FIVB)FDA Link
01/2019 - 06/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 11/2007
3Valproic Acid (Depakote)FDA LinkGeneric
06/2022 - 09/2007
3Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 12/2017
3Biological ProductsIBA
08/2019 - 11/2007
3MethyltransferasesIBA
10/2016 - 02/2006
3epidermal growth factor receptor VIIIIBA
07/2015 - 12/2007
2Levetiracetam (Keppra)FDA LinkGeneric
06/2022 - 01/2021
2Angiogenesis InhibitorsIBA
01/2022 - 04/2010
2Circulating Tumor DNAIBA
01/2022 - 01/2021
2GadoliniumIBA
12/2021 - 09/2010
2Contrast MediaIBA
12/2021 - 05/2018
2depatuxizumab mafodotinIBA
01/2021 - 01/2019
2EnzymesIBA
03/2020 - 01/2011
2Proteins (Proteins, Gene)FDA Link
03/2020 - 08/2003
2Monoclonal AntibodiesIBA
01/2019 - 02/2016
2Rituximab (Mabthera)FDA Link
01/2019 - 12/2017
2enzastaurinIBA
03/2012 - 03/2010
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2009 - 02/2006
2Imatinib Mesylate (Gleevec)FDA Link
10/2008 - 02/2006
2Irinotecan (Camptosar)FDA LinkGeneric
09/2007 - 02/2006
2Calmodulin-Binding Proteins (Caldesmon)IBA
06/2005 - 08/2003
1selinexorIBA
01/2022
1ceritinibIBA
01/2022
1LacosamideFDA Link
08/2021
1Lamotrigine (Lamictal)FDA LinkGeneric
08/2021
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
05/2021
1N 30IBA
01/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Oxygen (Dioxygen)IBA
10/2020
1Indigo Carmine (Indigo Blue)IBA
03/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2019
1Prednisone (Sone)FDA LinkGeneric
01/2019
1Teniposide (VM 26)FDA Link
01/2019
1vasectrin IIIIBA
01/2018
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2017

Therapy/Procedure

57Drug Therapy (Chemotherapy)
10/2022 - 03/2003
52Radiotherapy
10/2022 - 03/2003
26Therapeutics
01/2022 - 05/2005
9Chemoradiotherapy
01/2020 - 05/2008
6Aftercare (After-Treatment)
05/2021 - 12/2007
5Precision Medicine
01/2020 - 01/2010
4Stem Cell Transplantation
12/2017 - 05/2005
2Palliative Care (Palliative Therapy)
01/2021 - 12/2020
2Adjuvant Chemotherapy
12/2014 - 12/2007
1Vocational Rehabilitation
12/2022
1Activities of Daily Living (ADL)
08/2021
1Ambulatory Care (Outpatient Care)
05/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021
1Conformal Radiotherapy
01/2021
1Oral Administration
11/2016